NOUGUES MAXIMO F (Chief Financial Officer) received a stock award from PUMA BIOTECHNOLOGY, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/11/2025ACC: 0001437749-25-003461
Officer· Chief Financial Officer
Since Nov 2018
+146.52K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
146.52K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+61.46K
Price / share
—
Trade value
—
% of position
40.4%
2/7/2025
152.29K→213.75K
Total
Net shares
+61.46K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/7/2025 | A · Award | +61.46K | — | — | 40.4% | 152.29K | 213.75K |
| Total | +61.46K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
85.07K shares
Shares
+85.07K
Strike price
2.78
Held after
85.07K
Exercisable
—
2/7/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock85.07K shares | 2/7/2025 | A · Award | +85.07K | 2.78 | — | 85.07K |